跳至主要内容
临床试验/CTRI/2018/07/014969
CTRI/2018/07/014969进行中(未招募)4 期

A Randomized Double Blind Placebo Controlled Comparative Study to Evaluate the Efficacy and Safety of KSM-66 Ashwagandha (Withania Somnifera) Capsules 300 mg on Muscle Strength and Recovery in Sports Persons - KSM-66/PMS/2017/01,v1.1

Shri Kartikeya Pharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Male and female subjects with age from18 to 45 years who are sports persons
  • 2.Willing to provide EC approved written informed consent.
  • 3.Ability to understand the risks and benefits of the protocol
  • 4.Subject with History of Gymnasium visit since last three months of Screening
  • 5.Subject willing to follow the same Exercise and diet regime for study period as prescribed by the study protocol
  • 6.Men and women of childbearing potential accepting to use adequate birth control measures, as discussed with the study doctor, until the end of study.
  • 7.Subjects with good health as determined by:
  • 8.Medical history
  • 9.Physical examination
  • 10.Clinical judgment of the investigator
  • 11.Clinical laboratory examination (subjects with clinically acceptable range during baseline screening)..

排除标准

  • 1.Subjects already on nutritional / Energy supplements, medication or steroids to enhance physical performance
  • 2.Any history of drug abuse, smoking 10+ cigarettes day or consuming more than 14 grams of alcohol daily,
  • 3.Subjects planning to participate in any Sports event during the study period
  • 4.Weight loss of >5kg in the past 3 months
  • 5.History of any orthopedic injury or surgery in the past 6 months
  • 6.Participation in any clinical studies in the past 3 months
  • 7.Subject diagnosed with heart disease, diabetes, stroke or other neurological disorders or depression
  • 8.Subject with significant medication use (blood pressure, beta-blockers, inhaled beta agonists, hormonal contraceptives, corticosteroid use within prior three months, psychotropic medication use within prior eight weeks)
  • 9.Hypersensitivity to Ashwagandha
  • 10.Subjects with history of any prohibited drugs use
  • 11.Any criteria, which in the opinion of the Investigator, suggests that the subject would not be compliant with the study protocol.

研究者

相似试验